Usp18 Driven Enforced Viral Replication in Dendritic Cells Contributes to Break of Immunological Tolerance in Autoimmune Diabetes

PLoS Pathogens

Volumn 9, Issue 10, 2013, Pages

  Honke, Nadine ^a,b   Shaabani, Namir ^a,b   Zhang, Dong Er ^c   Iliakis, George ^a   Xu, Haifeng C ^a,b   Häussinger, Dieter ^b   Recher, Mike ^d   Löhning, Max ^e   Lang, Philipp A ^b   Lang, Karl S ^a,b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 INTERFERON; AUTOANTIGEN; CROSS REACTING ANTIGEN; DIPHTHERIA TOXIN; RIBAVIRIN; UNCLASSIFIED DRUG; USP 18 PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD GLUCOSE MONITORING; BONE MARROW; CD8+ T LYMPHOCYTE; CHIMERA; CONTROLLED STUDY; DENDRITIC CELL; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLUCOSE TOLERANCE TEST; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; LISTERIA MONOCYTOGENES; LISTERIOSIS; LYMPHOCYTE TRANSFER; MOUSE; NONHUMAN; VIRUS PLAQUE; VIRUS REPLICATION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD11C; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; GENE DELETION; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, KNOCKOUT; UBIQUITIN THIOLESTERASE; VIRUS REPLICATION;

EID: 84887305559     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003650     Document Type: Article

References (50)

1. Lehuen A, Diana J, Zaccone P, Cooke A, (2010) Immune cell crosstalk in type 1 diabetes. Nature reviews Immunology 10: 501-513.
2. Hyoty H, Taylor KW, (2002) The role of viruses in human diabetes. Diabetologia 45: 1353-1361.
3. Roep BO, Hiemstra HS, Schloot NC, De Vries RR, Chaudhuri A, et al. (2002) Molecular mimicry in type 1 diabetes: immune cross-reactivity between islet autoantigen and human cytomegalovirus but not Coxsackie virus. Annals of the New York Academy of Sciences 958: 163-165.
4. Schloot NC, Willemen SJ, Duinkerken G, Drijfhout JW, de Vries RR, et al. (2001) Molecular mimicry in type 1 diabetes mellitus revisited: T-cell clones to GAD65 peptides with sequence homology to Coxsackie or proinsulin peptides do not crossreact with homologous counterpart. Human immunology 62: 299-309.
5. Yoon JW, Austin M, Onodera T, Notkins AL, (1979) Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. The New England journal of medicine 300: 1173-1179.
6. Ramondetti F, Sacco S, Comelli M, Bruno G, Falorni A, et al. (2012) Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry. Diabetic medicine: a journal of the British Diabetic Association 29: 761-766.
7. Stene LC, Oikarinen S, Hyoty H, Barriga KJ, Norris JM, et al. (2010) Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes 59: 3174-3180.
8. Foxman EF, Iwasaki A, (2011) Genome-virome interactions: examining the role of common viral infections in complex disease. Nature reviews Microbiology 9: 254-264.
9. Smyth DJ, Cooper JD, Bailey R, Field S, Burren O, et al. (2006) A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nature genetics 38: 617-619.
10. von Herrath M, (2009) Diabetes: A virus-gene collaboration. Nature 459: 518-519.
11. Pietropaolo M, Castano L, Babu S, Buelow R, Kuo YL, et al. (1993) Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen. The Journal of clinical investigation 92: 359-371.
12. Karjalainen J, Martin JM, Knip M, Ilonen J, Robinson BH, et al. (1992) A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. The New England journal of medicine 327: 302-307.
13. Cavallo MG, Fava D, Monetini L, Barone F, Pozzilli P, (1996) Cell-mediated immune response to beta casein in recent-onset insulin-dependent diabetes: implications for disease pathogenesis. Lancet 348: 926-928.
14. Atkinson MA, Bowman MA, Kao KJ, Campbell L, Dush PJ, et al. (1993) Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes. The New England journal of medicine 329: 1853-1858.
15. Vaarala O, Klemetti P, Savilahti E, Reijonen H, Ilonen J, et al. (1996) Cellular immune response to cow's milk beta-lactoglobulin in patients with newly diagnosed IDDM. Diabetes 45: 178-182.
16. Judkowski VA, Allicotti GM, Sarvetnick N, Pinilla C, (2004) Peptides from common viral and bacterial pathogens can efficiently activate diabetogenic T-cells. Diabetes 53: 2301-2309.
17. Masala S, Paccagnini D, Cossu D, Brezar V, Pacifico A, et al. (2011) Antibodies recognizing Mycobacterium avium paratuberculosis epitopes cross-react with the beta-cell antigen ZnT8 in Sardinian type 1 diabetic patients. PloS one 6: e26931.
18. Lammi N, Karvonen M, Tuomilehto J, (2005) Do microbes have a causal role in type 1 diabetes? Medical science monitor: international medical journal of experimental and clinical research 11: RA63-69.
19. Turley SJ, Fletcher AL, Elpek KG, (2010) The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs. Nature reviews Immunology 10: 813-825.
20. Zinkernagel RM, (2000) Localization dose and time of antigens determine immune reactivity. Semin Immunol 12: 163-171.
21. Zinkernagel RM, Ehl S, Aichele P, Oehen S, Kundig T, et al. (1997) Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol Rev 156: 199-209.
22. George TC, Bilsborough J, Viney JL, Norment AM, (2003) High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro. European journal of immunology 33: 502-511.
23. Kang HK, Liu M, Datta SK, (2007) Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells. Journal of immunology 178: 7849-7858.
24. Lang KS, Recher M, Navarini AA, Harris NL, Lohning M, et al. (2005) Inverse correlation between IL-7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulation. European journal of immunology 35: 738-745.
25. Aichele P, Brduscha-Riem K, Zinkernagel RM, Hengartner H, Pircher H, (1995) T cell priming versus T cell tolerance induced by synthetic peptides. The Journal of experimental medicine 182: 261-266.
26. Honke N, Shaabani N, Cadeddu G, Sorg UR, Zhang DE, et al. (2012) Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nature immunology 13: 51-57.
27. Ohashi PS, Oehen S, Buerki K, Pircher H, Ohashi CT, et al. (1991) Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65: 305-317.
28. Jung S, Unutmaz D, Wong P, Sano G-I, De los Santos K, et al. (2002) In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17: 211-220.
29. Recher M, Lang KS, Navarini A, Hunziker L, Lang PA, et al. (2007) Extralymphatic virus sanctuaries as a consequence of potent T-cell activation. Nature medicine 13: 1316-1323.
30. Lang PA, Contaldo C, Georgiev P, El-Badry AM, Recher M, et al. (2008) Aggravation of viral hepatitis by platelet-derived serotonin. Nature medicine 14: 756-761.
31. Gessner A, Lother H, (1989) Homologous interference of lymphocytic choriomeningitis virus involves a ribavirin-susceptible block in virus replication. Journal of virology 63: 1827-1832.
32. Malakhova OA, Kim KI, Luo JK, Zou W, Kumar KG, et al. (2006) UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. EMBO J 25: 2358-2367.
33. Ritchie KJ, Hahn CS, Kim KI, Yan M, Rosario D, et al. (2004) Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection. Nat Med 10: 1374-1378.
34. Lang KS, Recher M, Junt T, Navarini AA, Harris NL, et al. (2005) Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nature medicine 11: 138-145.
35. Pircher H, Burki K, Lang R, Hengartner H, Zinkernagel RM, (1989) Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342: 559-561.
36. Lenzen S, (2008) The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51: 216-226.
37. Hunziker L, Recher M, Macpherson AJ, Ciurea A, Freigang S, et al. (2003) Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections. Nature immunology 4: 343-349.
38. Coppieters KT, Wiberg A, von Herrath MG, (2012) Viral infections and molecular mimicry in type 1 diabetes. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica 120: 941-949.
39. von Herrath MG, Dockter J, Oldstone MB, (1994) How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1: 231-242.
40. Christen S, Coppieters K, Rose K, Holdener M, Bayer M, et al. (2013) Blockade but not overexpression of the junctional adhesion molecule C influences virus-induced type 1 diabetes in mice. PloS one 8: e54675.
41. Freigang S, Probst HC, van den Broek M, (2005) DC infection promotes antiviral CTL priming: the 'Winkelried' strategy. Trends in immunology 26: 13-18.
42. Cong XL, Lo MC, Reuter BA, Yan M, Fan JB, et al. (2012) Usp18 promotes conventional CD11b+ dendritic cell development. Journal of immunology 188: 4776-4781.
43. Seifert U, Bialy LP, Ebstein F, Bech-Otschir D, Voigt A, et al. (2010) Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 142: 613-624.
44. Le Bon A, Etchart N, Rossmann C, Ashton M, Hou S, et al. (2003) Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat Immunol 4: 1009-1015.
45. Longhi MP, Trumpfheller C, Idoyaga J, Caskey M, Matos I, et al. (2009) Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J Exp Med 206: 1589-1602.
46. Millar DG, Garza KM, Odermatt B, Elford AR, Ono N, et al. (2003) Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo. Nature medicine 9: 1469-1476.
47. Nejentsev S, Walker N, Riches D, Egholm M, Todd JA, (2009) Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324: 387-389.
48. Heinig M, Petretto E, Wallace C, Bottolo L, Rotival M, et al. (2010) A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature 467: 460-464.
49. Santin I, Moore F, Grieco FA, Marchetti P, Brancolini C, et al. (2012) USP18 is a key regulator of the interferon-driven gene network modulating pancreatic beta cell inflammation and apoptosis. Cell death & disease 3: e419.
50. Lang KS, Georgiev P, Recher M, Navarini AA, Bergthaler A, et al. (2006) Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. The Journal of clinical investigation 116: 2456-2463.